Fierce Pharma: Amid contract manufacturing wind-down, Moderna advances production efforts for cancer programs
Additional Content
Fierce Pharma: Bristol Myers CEO ‘increasingly confident’ company can handle IRA pricing on Eliquis
Schwab Network: Palantir’s (PLTR) Pivot into the Commercial Market
Reuters: Lloyds profit slides 14% as slow economy and rising costs bite
City AM: Aston Martin loses over £200m ahead of production ramp-up
Reuters: AT&T beats estimates for subscriber additions on demand for higher-priced plans
Reuters: Comcast misses quarterly revenue estimates on weak studio, theme park business
BNN Bloomberg: Outlook on Netflix subscriber growth
Reuters: Oilfield services firms SLB, Halliburton post profit gains on global demand
